129 related articles for article (PubMed ID: 27761938)
1. Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Inzelberg R; Flash S; Friedman E; Azizi E
Ann Neurol; 2016 Dec; 80(6):811-820. PubMed ID: 27761938
[TBL] [Abstract][Full Text] [Related]
2. Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.
Lubbe SJ; Escott-Price V; Brice A; Gasser T; Pittman AM; Bras J; Hardy J; Heutink P; Wood NM; Singleton AB; Grosset DG; Carroll CB; Law MH; Demenais F; Iles MM; ; Bishop DT; Newton-Bishop J; Williams NM; Morris HR;
Neurobiol Aging; 2016 Dec; 48():222.e1-222.e7. PubMed ID: 27640074
[TBL] [Abstract][Full Text] [Related]
3. Skin Pigmentation Genetics for the Clinic.
Ainger SA; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
Dermatology; 2017; 233(1):1-15. PubMed ID: 28463841
[TBL] [Abstract][Full Text] [Related]
4. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
5. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
6. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
[TBL] [Abstract][Full Text] [Related]
8. The role of melanocortin 1 receptor in cutaneous malignant melanoma: along the mitogen-activated protein kinase pathway.
Steck MB
Biol Res Nurs; 2014 Oct; 16(4):421-8. PubMed ID: 24443365
[TBL] [Abstract][Full Text] [Related]
9. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
[TBL] [Abstract][Full Text] [Related]
10. The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanoma.
Elincx-Benizri S; Inzelberg R; Greenbaum L; Cohen OS; Yahalom G; Laitman Y; Djaldetti R; Orlev Y; Scope A; Azizi E; Friedman E; Hassin-Baer S
J Mol Neurosci; 2014 Dec; 54(4):820-5. PubMed ID: 25284244
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
12. A Review of the Association Between Parkinson Disease and Malignant Melanoma.
Disse M; Reich H; Lee PK; Schram SS
Dermatol Surg; 2016 Feb; 42(2):141-6. PubMed ID: 26771684
[TBL] [Abstract][Full Text] [Related]
13. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.
Jannot AS; Meziani R; Bertrand G; Gérard B; Descamps V; Archimbaud A; Picard C; Ollivaud L; Basset-Seguin N; Kerob D; Lanternier G; Lebbe C; Saiag P; Crickx B; Clerget-Darpoux F; Grandchamp B; Soufir N; Melan-Cohort
Eur J Hum Genet; 2005 Aug; 13(8):913-20. PubMed ID: 15889046
[TBL] [Abstract][Full Text] [Related]
14. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
Tell-Marti G; Puig-Butille JA; Potrony M; Badenas C; Milà M; Malvehy J; Martí MJ; Ezquerra M; Fernández-Santiago R; Puig S
Ann Neurol; 2015 May; 77(5):889-94. PubMed ID: 25631192
[TBL] [Abstract][Full Text] [Related]
15. Parkinson disease and malignant melanoma in first-degree relatives of patients with early-onset melanoma.
Olsen JH; Jørgensen TL; Rugbjerg K; Friis S
Epidemiology; 2011 Jan; 22(1):109-12. PubMed ID: 21030864
[TBL] [Abstract][Full Text] [Related]
16. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
17. Melanoma susceptibility genes.
Newton-Bishop J; Gruis N
Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
[No Abstract] [Full Text] [Related]
18. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
[TBL] [Abstract][Full Text] [Related]
19. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
[TBL] [Abstract][Full Text] [Related]
20. The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder.
Gan-Or Z; Mohsin N; Girard SL; Montplaisir JY; Ambalavanan A; Strong S; Mallett V; Laurent SB; Bourassa CV; Boivin M; Langlois M; Arnulf I; Högl B; Frauscher B; Monaca C; Desautels A; Gagnon JF; Postuma RB; Dion PA; Dauvilliers Y; Dupre N; Alcalay RN; Rouleau GA
Neurobiol Aging; 2016 Jul; 43():180.e7-180.e13. PubMed ID: 27131830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
